SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001290696-04-000002
Filing Date
2004-05-17
Accepted
2004-05-17 16:08:27
Documents
1
Period of Report
2004-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001290696d20040517f3f.html 3  
1 PRIMARY DOCUMENT c0001290696d20040517f3f.xml 3 8712
  Complete submission text file 0001290696-04-000002.txt   10404
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address 410-631-5039
RUBIN ASHER M (Reporting) CIK: 0001290696 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23736 | Film No.: 04812534